7Baggers
 belite bio (nasdaq:blte) sees strong trading volume - here's why  MarketBeat Wed, 24 Sep 2025 15:43:50 GMT
 belite bio (nasdaq:blte) upgraded at wall street zen  MarketBeat Wed, 24 Sep 2025 03:56:15 GMT
 belite bio, inc (blte) investor outlook: exploring a promising 30.80% upside potential  DirectorsTalk Interviews Tue, 23 Sep 2025 09:15:06 GMT
 belite bio (nasdaq:blte) stock rating upgraded by wall street zen  MarketBeat Tue, 23 Sep 2025 08:56:30 GMT
 belite bio (nasdaq:blte) raised to hold at zacks research  MarketBeat Mon, 22 Sep 2025 07:00:00 GMT
 hc wainwright has positive outlook of belite bio q3 earnings  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 belite bio (nasdaq:blte) raised to hold at wall street zen  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 belite bio (nasdaq:blte) upgraded to "hold" at wall street zen  MarketBeat Sat, 20 Sep 2025 05:19:49 GMT
 belite bio (nasdaq:blte) raised to "hold" at zacks research  MarketBeat Fri, 19 Sep 2025 11:15:37 GMT
 belite bio (nasdaq:blte) upgraded at zacks research  Defense World Fri, 19 Sep 2025 07:00:00 GMT
 belite bio (nasdaq:blte) sees strong trading volume - time to buy?  MarketBeat Thu, 18 Sep 2025 17:11:00 GMT
 what is hc wainwright's forecast for belite bio q3 earnings?  MarketBeat Thu, 18 Sep 2025 10:56:03 GMT
 what is hc wainwright’s estimate for belite bio q3 earnings?  Defense World Thu, 18 Sep 2025 05:05:18 GMT
 published on: 2025-09-18 01:29:35  خودرو بانک Wed, 17 Sep 2025 22:00:39 GMT
 published on: 2025-09-17 04:57:30  newser.com Wed, 17 Sep 2025 09:57:30 GMT
 published on: 2025-09-17 01:43:40  newser.com Wed, 17 Sep 2025 06:43:40 GMT
 belite bio secures upsized pipe financing of up to us$275 million  Global Legal Chronicle Wed, 17 Sep 2025 00:00:00 GMT
 published on: 2025-09-16 14:40:43  خودرو بانک Tue, 16 Sep 2025 11:12:14 GMT
 Belite Bio concludes phase 3 DRAGON study for Stargardt disease  Ophthalmology Times Tue, 16 Sep 2025 07:00:00 GMT
 published on: 2025-09-15 16:13:04  خودرو بانک Mon, 15 Sep 2025 12:47:01 GMT
 Belite Bio wraps up Phase III trial of Stargardt disease treatment  Clinical Trials Arena Mon, 15 Sep 2025 07:00:00 GMT
 belite bio shares climb amid clinical progress  TipRanks Mon, 15 Sep 2025 07:00:00 GMT
 belite bio (nasdaq:blte) shares gap up - here's why  MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
 belite bio completes last subject visit in phase 3 stargardt trial  Investing.com Australia Sat, 13 Sep 2025 05:49:10 GMT
 Belite Bio Announces Completion of DRAGON, a 2-Year, Phase  GlobeNewswire Fri, 12 Sep 2025 07:00:00 GMT
 upcoming events  FinancialContent Fri, 12 Sep 2025 07:00:00 GMT
 belite bio, inc. adr (blte) gets a buy from benchmark co.  The Globe and Mail Thu, 11 Sep 2025 07:00:00 GMT
 belite bio (nasdaq:blte) shares gap up - should you buy?  MarketBeat Wed, 10 Sep 2025 17:24:43 GMT
 published on: 2025-09-10 00:33:11  Newser Wed, 10 Sep 2025 05:33:11 GMT
 belite bio at h.c. wainwright: tinlarebant’s promising future  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 belite bio to raise $275 million in private placement  MarketScreener Mon, 08 Sep 2025 12:52:47 GMT
 belite bio secures up to $275m in upsized private placement  MarketScreener Mon, 08 Sep 2025 07:00:00 GMT
 belite bio (nasdaq:blte) stock price down 2.3% - here's why  MarketBeat Sat, 06 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 12:14:19  Newser Fri, 05 Sep 2025 17:14:19 GMT
 published on: 2025-09-04 01:16:45  Newser Thu, 04 Sep 2025 06:16:45 GMT
 published on: 2025-09-03 05:48:33  خودرو بانک Wed, 03 Sep 2025 19:07:11 GMT
 published on: 2025-09-01 21:27:34  Newser Tue, 02 Sep 2025 02:27:34 GMT
 published on: 2025-09-01 04:51:07  Newser Mon, 01 Sep 2025 09:51:07 GMT
 published on: 2025-08-30 22:10:45  Newser Sun, 31 Aug 2025 03:10:45 GMT
 published on: 2025-08-30 21:28:18  Newser Sun, 31 Aug 2025 02:28:18 GMT
 published on: 2025-08-30 21:22:35  Newser Sun, 31 Aug 2025 02:22:35 GMT

Belite Bio, Inc
(NASDAQ:BLTE) 

BLTE stock logo

Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular degeneration and autosomal recessive stargardt diseases. The company is headquartered in San Diego, California.

Founded: 2016
IPO Price: $6 (Apr 29, 2022)
CEO / Founder: Dr. Tom Lin 
Sector: Technology
Industry: General

Share this website to your friends